Table 3.
Complete blood count profiles of the participants (N = 150).
| Parameters | Groups | ||||
|---|---|---|---|---|---|
| Control group | Type 1 diabetic patients | Type 1 diabetic patients with COVID-19 | Test value | p value | |
| RBCs (×1012 cells/l) | 4.59 ± 0.77 | 4.54 ± 0.4 | 4.27 ± 0.84b | 3.006 | 0.053 |
| WBCs (×109 cells/l) | 6.14 ± 0.71 | 7.27 ± 0.91a | 9.68 ± 1.23ab | 169.201 | <0.001 |
| LYM (%) | 29.32 ± 6.25 | 29.13 ± 5.65 | 22.27 ± 3.68ab | 28.063 | <0.001 |
| PLT (×109 cells/l) | 261.04 ± 41.53 | 288.2 ± 62.33a | 233.88 ± 42.1ab | 14.694 | <0.001 |
Results are expressed as mean ± SD. RBCs: red blood cells; WBCs: white blood cells; LYM: lymphocytes; PLT: platelets. aSignificantly different from the control group. bSignificantly different from the type 1 diabetic patients. p < 0.05 is considered significant.